Prognostic Value of Platelet-to-Lymphocyte Ratio Combined with CHA2DS2-VASc Score for Nonvalvular Atrial Fibrillation Induced Cardiogenic Cerebral Embolism
Authors:
Open Access
- 1 December 2023
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 16, 5937-5947
Abstract
Aim: To determine the predictive significance of the platelet-to-lymphocyte ratio (PLR) combined with the CHA2DS2-VASc score for cardiogenic cerebral embolism (CCE) in patients with nonvalvular atrial fibrillation (NVAF). Methods: A total of 553 patients with NVAF were included in this retrospective study. The general data, PLR, CHA2DS2-VASc score and echocardiography indicators were compared. The risk factors for CCE and the predictive value of PLR and CHA2DS2-VASc were analyzed. Stratified analysis was performed based on the cut-off value. Least absolute shrinkage and selection operator (LASSO) regression analysis was utilized to build a model. The relationship between risk score and different anticoagulants was evaluated. Results: Multiple regression analysis showed hypertension (OR=3.95, 95% CI=2.12– 7.35, p=1.40× 10− 5), diabetes mellitus (OR=2.95, 95% CI=1.57– 5.58, p=7.65× 10− 4), PLR (OR=1.01, 95% CI=1.00– 1.01, p< 10− 6), creatinine level (OR=1.01, 95% CI=1.00– 1.02, p=7.44× 10− 3), left atrial diameter (LAD) (OR=1.90, 95% CI=1.13– 3.19, p=1.51× 10− 2), ejection fraction (EF) (OR=0.93, 95% CI=0.87– 0.98, p=8.06× 10− 3) and CHA2DS2-VASc score (OR=3.79, 95% CI=2.95– 4.85, p< 10− 6) were independent risk factors for CCE. A one-way linear analysis also showed the above seven indexes were significantly correlated with CCE (F=56.4, p< 10− 6). The area under the receiver operating characteristic (ROC) curve of PLR and CHA2DS2-VASc score was 0.760 (95% CI:0.721– 0.800), and 0.855 (95% CI: 0.824– 0.886), respectively. Pearson correlation analysis showed that PLR was correlated with CHA2DS2-VASc score (r=0.331, p< 10− 6). Stratified analysis indicated there was a positive correlation between different risk group (p< 10− 6). Using the LASSO model, a composite indicator displayed differential power for distinguishing CCE with an AUC value of 0.884 (95% CI: 0.857– 0.911). Patients with dabigatran and rivaroxaban exhibited higher risk score than those with warfarin (warfarin vs dabigatran, p=1.40× 10− 2; warfarin vs rivaroxaban p=3.00× 10− 3). Conclusion: PLR and CHA2DS2-VASc score are independent risk factors for CCE with NVAF, and the combination of the two indices can improve the prediction of CCE.Keywords
This publication has 32 references indexed in Scilit:
- Is Atrial Fibrillation a Preventable Disease?JACC, 2017
- Left ventricular diastolic dysfunction is associated with atrial remodeling and risk or presence of stroke in patients with paroxysmal atrial fibrillationJournal of Cardiology, 2016
- Platelet haemostatic function in psychiatric disorders: Effects of antidepressants and antipsychotic drugsThe World Journal of Biological Psychiatry, 2016
- Inflammation and the pathogenesis of atrial fibrillationNature Reviews Cardiology, 2015
- Cardiac diastolic dysfunction predicts in-hospital mortality in acute ischemic stroke with atrial fibrillationJournal of the Neurological Sciences, 2014
- Platelet-to-Lymphocyte Ratio: A Novel Marker for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease PatientsPLOS ONE, 2013
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Cardioembolic Stroke: Clinical Features, Specific Cardiac Disorders and PrognosisCurrent Cardiology Reviews, 2010
- Inflammation in the genesis and perpetuation of atrial fibrillationEuropean Heart Journal, 2005
- Validation of Clinical Classification Schemes for Predicting StrokeJAMA, 2001